Evidence map›Paper›PMID 25582295›Full record

ReviewNeuropharmacology2015

ASICs as therapeutic targets for migraine.

Greg Dussor

Abstract readReview
In one paragraph

Review in Neuropharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 59 citations in OpenAlex.

  1. Acid-sensing ion channels as sensors of brain metabolic state.Pflugers Archiv : European journal of physiology · 2026
    Review
  2. ASIC1a mediated nucleus pulposus cells pyroptosis and glycolytic crosstalk as a molecular basis for intervertebral disc degeneration.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  3. Calcium Ions in the Physiology and Pathology of the Central Nervous System.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Article
  6. Review
  7. Future targets for migraine treatment beyond CGRP.The journal of headache and pain · 2023
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Migraine: Calcium Channels and Glia.International journal of molecular sciences · 2021
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Cross-talk signaling in the trigeminal ganglion: role of neuropeptides and other mediators.Journal of neural transmission (Vienna, Austria : 1996) · 2020
    Review
  19. Current understanding of trigeminal ganglion structure and function in headache.Cephalalgia : an international journal of headache · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Greg DussorThe University of Texas at Dallas, School of Behavioral and Brain Sciences, GR-41, 800 West Campbell Road, Richardson, TX, 75080, USA. Electronic address: gregory.dussor1@utdallas.edu.
The University of Texas at Dallas · US

Funding

The Role of ASICs in Migraine PathophysiologyR01NS072204 · NINDS · UNIVERSITY OF TEXAS DALLAS · PI DUSSOR, GREGORY O · 2011 to 2015
$1.9M
AMPK ACTIVATORS FOR THE TREATMENT OF POST-SURGICAL PAINR01GM102575 · NIGMS · UNIVERSITY OF TEXAS DALLAS · PI DUSSOR, GREGORY O, PRICE, THEODORE J. · 2013 to 2016
$1.1M
NIGMS NIH HHS GM102575NIGMS NIH HHS R01 GM102575NINDS NIH HHS NS072204NINDS NIH HHS R01 NS072204
6 · The paper itself

Abstract

Migraine is the most common neurological disorder and one of the most common chronic pain conditions. Despite its prevalence, the pathophysiology leading to migraine is poorly understood and the identification of new therapeutic targets has been slow. Several processes are currently thought to contribute to migraine including altered activity in the hypothalamus, cortical-spreading depression (CSD), and afferent sensory input from the cranial meninges. Decreased extracellular pH and subsequent activation of acid-sensing ion channels (ASICs) may contribute to each of these processes and may thus play a role in migraine pathophysiology. Although few studies have directly examined a role of ASICs in migraine, studies directly examining a connection have generated promising results including efficacy of ASIC blockers in both preclinical migraine models and in human migraine patients. The purpose of this review is to discuss the pathophysiology thought to contribute to migraine and findings that implicate decreased pH and/or ASICs in these events, as well as propose issues to be resolved in future studies of ASICs and migraine. This article is part of the Special Issue entitled 'Acid-Sensing Ion Channels in the Nervous System'.

Indexed as

Acid Sensing Ion Channel BlockersAcid Sensing Ion ChannelsAnimalsCortical Spreading DepressionHumansMigraine DisordersAcid Sensing Ion Channel BlockersAcid Sensing Ion ChannelsASICCortical spreading depressionDuraHeadacheMeningesMigraine

Identifiers

PMID25582295
PMCPMC4458434
OpenAlexW2045219565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.